Logarithmic quantitation model using serum ferritin to estimate iron overload in secondary haemochromatosis.
Open Access
- 1 April 1996
- journal article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 74 (4), 323-327
- https://doi.org/10.1136/adc.74.4.323
Abstract
Nineteen children and adolescents receiving repeated transfusions and subcutaneous desferrioxamine treatment were investigated in an attempt to quantitate iron overload non-invasively. Before patients were started on desferrioxamine individual relationships were correlated for 12 to 36 months between transfused iron, absorbed iron estimated gastrointestinally, and increasing serum ferritin concentrations. Patients with inflammation, increased liver enzymes, or haemolysis were excluded from analysis. The relationship between the variables could be described by a logarithmic regression curve (y = transfused iron [plus eventually gastrointestinally absorbed iron] = iron overload = a+b log [x = serum ferritin]) for each individual patient. All patients showed close correlation (R2) between x and y (median R2 of 0.909, 0.98, and 0.92 in thalassaemia, aplastic anaemia, and sickle cell anaemia patients, respectively). When started on desferrioxamine, current serum ferritin concentrations were used to derive the iron overload from each individual regression curve. The derived estimated iron overload ranged from 0.6 g to 31 g. Left ventricular dilatation was observed in three patients with beta thalassaemia and in one patient with aplastic anaemia with median iron overload of 20.7 (14.1-31.3) g and 24.0 g respectively. Hypothyroidism was found in four patients with beta thalassaemia and one patient with aplastic anaemia with iron overload between 14.7 (6.8 and 26.1) g and 15.1 g respectively. Human growth hormone deficiency was detected in three patients with beta thalassaemia with an iron overload of 4.2 (3.5-6.8) g; all three patients had excellent desferrioxamine compliance.Keywords
This publication has 16 references indexed in Scilit:
- Prolonged survival in patients with beta-thalassemia major treated with deferoxamineThe Journal of Pediatrics, 1991
- Non‐invasive quantitation of liver iron‐overload by magnetic resonance imagingBritish Journal of Haematology, 1990
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- Reappraisal of High-Dose Desferrioxamine TherapyActa Haematologica, 1986
- Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia MajorNew England Journal of Medicine, 1985
- Internal Distribution of Excess Iron and Sources of Serum Ferritin in Patients with ThalassaemiaScandinavian Journal of Haematology, 1983
- Magnetic-Susceptibility Measurement of Human Iron StoresNew England Journal of Medicine, 1982
- CORRELATION BETWEEN COMPUTED TOMOGRAPHIC VALUES AND LIVER IRON CONTENT IN THALASSÆMIA MAJOR WITH IRON OVERLOADThe Lancet, 1979
- An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overloadJournal of Clinical Pathology, 1972
- Iron in the heartThe American Journal of Medicine, 1971